Novel diabetes mellitus treatment: Mature canine insulin production by canine striated muscle through gene therapy

Domestic Animal Endocrinology

Volumn 43, Issue 1, 2012, Pages 16-25

  Niessen, S J M ^a,b   Fernandez Fuente, M ^a   Mahmoud, A ^b   Campbell, S C ^b   Aldibbiat, A ^b   Huggins, C ^c   Brown, A E ^b   Holder, A ^a   Piercy, R J ^a   Catchpole, B ^a   Shaw, J A M ^b   Church, D B ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Diabetes mellitus; Dog; Gene therapy; Insulin; Muscle

Indexed keywords

DESMIN; INSULIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CELL LINE; DIABETES MELLITUS; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE THERAPY; GENETICS; HAMSTER; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; PLASMID; SKELETAL MUSCLE;

ANIMALS; CELL LINE; CRICETINAE; DESMIN; DIABETES MELLITUS; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE THERAPY; INSULIN; MICE; MUSCLE, SKELETAL; PLASMIDS;

ADENOVIRIDAE; CANIS FAMILIARIS; MURINAE;

EID: 84862141745     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2012.01.006     Document Type: Article

References (33)

1. Feldman E.C., Nelson R.W. Canine and Feline Endocrinology and Reproduction 2004, W. B. Saunders, New York, NY. 3rd ed.
2. Niessen S.J., Powney S., Guitian J., Niessen A.P.M., Pion P.D., Shaw J.A.M., Church D.B. Diabetes mellitus and euthanasia: how often and why?. J Vet Intern Med 2010, 24(6):1568.
3. Niessen SJ, Powney S, Guitian J, Niessen APM, Pion PD, Shaw JAM, Church DB. Development of a Measure of Quality of Life for Dogs with Diabetes Mellitus: the DIAQoL-Pet In: Proceedings British Small Animal Veterinary Congress: 402; 2009.
4. Niessen S.J., Powney S., Guitian J., Niessen A.P., Pion P.D., Shaw J.A., Church D.B. Evaluation of a quality-of-life tool for cats with diabetes mellitus. J Vet Intern Med 2010, 24:1098-1105.
5. Shaw J.A., Delday M.I., Hart A.W., Docherty H.M., Maltin C.A., Docherty K. Secretion of bioactive human insulin following plasmid-mediated gene transfer to non-neuroendocrine cell lines, primary cultures and rat skeletal muscle in vivo. J Endocrinol 2002, 172:653-672.
6. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992, 1:363-369.
7. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Felgner P.L. Direct gene transfer into mouse muscle in vivo. Science 1990, 247:1465-1468.
8. Draghia-Akli R., Hahn K.A., King G.K., Cummings K.K., Carpenter R.H. Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer. Mol Ther 2002, 6:830-836.
9. Tone C.M., Cardoza D.M., Carpenter R.H., Draghia-Akli R. Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs. Cancer Gene Ther 2004, 11:389-396.
10. Fewell J.G., MacLaughlin F., Mehta V., Gondo M., Nicol F., Wilson E., Smith L.C. Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation. Mol Ther 2001, 3:574-583.
11. Walker M.C., Mandell T.C., Crawford P.C., Simon G.G., Cahill K.S., Fernandes P.J., MacLeod J.N., Byrne B.J., Levy J.K. Expression of erythropoietin in cats treated with a recombinant adeno-associated viral vector. Am J Vet Res 2005, 66:450-456.
12. Mann C.J., Callejas D., Montane J., Ayuso E., Anguela X.M., Moya M., Leon X., et al. Gene therapy for type 1 diabetes by expressing insulin and glucokinase (GK) in skeletal muscle: pre-clinical studies in diabetic dogs (abstract). Mol Ther 2008, 16(suppl 1):S367.
13. Robbins D.C., Tager H.S., Rubenstein A.H. Biologic and clinical importance of proinsulin. N Engl J Med 1984, 310:1165-1175.
14. Wahren J., Ekberg K., Jörnvall H. C-peptide is a bioactive peptide. Diabetologia 2007, 50:503-509.
15. Pierson C.R., Zhang W., Sima A.A. Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration. J Neuropathol Exp Neurol 2003, 62:765-779.
16. Catchpole B., Ristic J.M., Fleeman L.M., Davison L.J. Canine diabetes mellitus: can old dogs teach us new tricks?. Diabetologia 2005, 48:1948-1956.
17. Richler C., Yaffe D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev Biol 1970, 23:1-22.
18. Fernandez-Fuente M., Ames E.G., Wagner M.L., Zhou H., Strom M., Zammit P., Mickelson J.R., et al. Assessment of the transformation of equine skin-derived fibroblasts to multinucleated skeletal myotubes following lentiviral-induced expression of equine myogenic differentiation 1. Am J Vet Res 2008, 69:1637-1645.
19. Shimamura M., Morishita R. Editorial [hot topic: naked plasmid DNA for gene therapy (guest editors: munehisa shimamura & ryuichi morishita)]. Curr Gene Ther 2011, 11:433.
20. Oberg J., Fall T., Lilliehook I. Validation of a species-optimized enzyme-linked immunosorbent assay for determination of serum concentrations of insulin in dogs. Vet Clin Pathol 2011, 2011:66-73.
21. Hay C.W., Docherty K. Enhanced expression of a furin-cleavable proinsulin. J Mol Endocrinol 2003, 31:597-607.
22. Lei P., Ogunade A., Kirkwood K.L., Laychock S.G., Andreadis S.T. Efficient production of bioactive insulin from human epidermal keratinocytes and tissue-engineered skin substitutes: implications for treatment of diabetes. Tissue Eng 2007, 13:2119-2131.
23. Zammit P., Beauchamp J. The skeletal muscle satellite cell: stem cell or son of stem cell?. Differentiation 2001, 68:193-204.
24. Tapscott S.J., Davis R.L., Thayer M.J., Adam M.A., Lassar A.B., Miller A.D. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 1989, 86:5434-5438.
25. Choi J., Costa M.L., Mermelstein C.S., Chagas C., Holtzer S., Holtzer H. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A 1990, 87:7988-7992.
26. Manthorpe M., Cornefert-Jensen F., Hartikka J., Felgner J., Rundell A., Margalith M., Dwarki V. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 1993, 4:419-431.
27. Points to consider on plasmid DNA vaccines for preventive infectious disease indications Food and Drug Administration, [docket No. 96N-0400], Accessed: December 19, 2011. http://www.fda.gov/cber/gdlns/plasmid.pdf.
28. Zhang W., Jin H., Hu Y., Yu Y., Li X., Ding Z., Kang Y., et al. Protective response against type 1 diabetes in nonobese diabetic mice after coimmunization with insulin and DNA encoding proinsulin. Hum Gene Ther 2010, 21:171-178.
29. Won J.C., Rhee B.D., Ko K.S. Glucose-responsive gene expression system for gene therapy. Adv Drug Deliv Rev 2009, 61:633-640.
30. Thulé P.M., Liu J., Phillips L.S. Glucose regulated production of human insulin in rat hepatocytes. Gene Ther 2000, 7:205-214.
31. Lan M.S., Wang H.W., Chong J., Breslin M.B. Coupling of glucose response element from L-type pyruvate kinase and G6Pase promoter enhances glucose responsive activity in hepatoma cells. Mol Cell Biochem 2007, 300:191-196.
32. Lu D., Tamemoto H., Shibata H., Saito I., Takeuchi T. Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin. Gene Ther 1998, 5:888-895.
33. Dong H., Woo S.L. Hepatic insulin production for type 1 diabetes. Trends Endocrinol Metab 2001, 12:441-446.